Cellulose nanofiber aerogel as a promising biomaterial for customized oral drug delivery
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62156489%3A43410%2F17%3A43910984" target="_blank" >RIV/62156489:43410/17:43910984 - isvavai.cz</a>
Výsledek na webu
<a href="https://doi.org/10.2147/IJN.S124318" target="_blank" >https://doi.org/10.2147/IJN.S124318</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.2147/IJN.S124318" target="_blank" >10.2147/IJN.S124318</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Cellulose nanofiber aerogel as a promising biomaterial for customized oral drug delivery
Popis výsledku v původním jazyce
Cellulose nanofiber (CNF) aerogels with favorable floatability and mucoadhesive properties prepared by the freeze-drying method have been introduced as new possible carriers for oral controlled drug delivery system. Bendamustine hydrochloride is considered as the model drug. Drug loading was carried out by the physical adsorption method, and optimization of drug-loaded formulation was done using central composite design. A very lightweight-aerogel-with-matrix system was produced with drug loading of 18.98%+-1.57%. The produced aerogel was characterized for morphology, tensile strength, swelling tendency in media with different pH values, floating behavior, mucoadhesive detachment force and drug release profiles under different pH conditions. The results showed that the type of matrix was porous and woven with excellent mechanical properties. The drug release was assessed by dialysis, which was fitted with suitable mathematical models. Approximately 69.205%+-2.5% of the drug was released in 24 hours in medium of pH 1.2, whereas ~78%+-2.28% of drug was released in medium of pH 7.4, with floating behavior for ~7.5 hours. The results of in vivo study showed a 3.25-fold increase in bioavailability. Thus, we concluded that CNF aerogels offer a great possibility for a gastroretentive drug delivery system with improved bioavailability.
Název v anglickém jazyce
Cellulose nanofiber aerogel as a promising biomaterial for customized oral drug delivery
Popis výsledku anglicky
Cellulose nanofiber (CNF) aerogels with favorable floatability and mucoadhesive properties prepared by the freeze-drying method have been introduced as new possible carriers for oral controlled drug delivery system. Bendamustine hydrochloride is considered as the model drug. Drug loading was carried out by the physical adsorption method, and optimization of drug-loaded formulation was done using central composite design. A very lightweight-aerogel-with-matrix system was produced with drug loading of 18.98%+-1.57%. The produced aerogel was characterized for morphology, tensile strength, swelling tendency in media with different pH values, floating behavior, mucoadhesive detachment force and drug release profiles under different pH conditions. The results showed that the type of matrix was porous and woven with excellent mechanical properties. The drug release was assessed by dialysis, which was fitted with suitable mathematical models. Approximately 69.205%+-2.5% of the drug was released in 24 hours in medium of pH 1.2, whereas ~78%+-2.28% of drug was released in medium of pH 7.4, with floating behavior for ~7.5 hours. The results of in vivo study showed a 3.25-fold increase in bioavailability. Thus, we concluded that CNF aerogels offer a great possibility for a gastroretentive drug delivery system with improved bioavailability.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2017
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
International Journal of Nanomedicine
ISSN
1176-9114
e-ISSN
—
Svazek periodika
12
Číslo periodika v rámci svazku
14 March
Stát vydavatele periodika
NZ - Nový Zéland
Počet stran výsledku
11
Strana od-do
2021-2031
Kód UT WoS článku
000396151900001
EID výsledku v databázi Scopus
2-s2.0-85015865201